Background
Distinguishing between neuromyelitis optica spectrum disorders (NMOSD) and neurosarcoidosis is particularly challenging based on magnetic resonance imaging (MRI) findings, especially in cases of longitudinally extensive myelitis. The serum-derived aquaporin-4 immunoglobulin G (AQP4-IgG) antibody is believed to play a pivotal role in the pathogenesis of NMOSD. 1 However, the mechanism whereby AQP4-IgG contributes to blood-brain barrier (BBB) leakage remains poorly characterized. Neurosarcoidosis is a subtype of sarcoidosis that involves multisystem granulomatosis characterized by non-caseating granulomas. Several pathological studies have revealed underlying microvascular changes in neurosarcoidosis. 2 Here, we compared the frequency of intracranial hemorrhagic lesions in neurosarcoidosis with that of NMOSD using T2*-weighted imaging (T2*WI) of the head, and discuss differences in the development of central nervous system lesions in both patient groups.
Methods
We retrospectively analyzed the medical records, including MRI findings, of a series of Japanese patients with neurosarcoidosis and NMOSD admitted to Tokyo Metropolitan Neurological Hospital, Tokyo, Japan, between 2013 and 2017. Neurosarcoidosis diagnoses had been made in these patients based on the Japanese sarcoidosis clinical or pathological criteria, and the presence of spinal or cranial lesions. 3 NMOSD was diagnosed based on the criteria for NMOSD with AQP4-IgG. 1 Based on the records, 13 patients with neurosarcoidosis and 36 patients with NMOSD with AQP4-IgG had been hospitalized during this period. Among these, we identified nine neurosarcoidosis patients and 28 NMOSD with AQP4-IgG patients who underwent T2*WI of the head. We compared and analyzed the clinical characteristics (age at head MRI, sex, number of cases with myelitis, hypertension, spinal cord compression and systemic steroid administration at head MRI) and head MRI findings (T2*WI lesion, gadolinium enhancement at T2*WI lesion) of each group.
Results
The sex ratio of neurosarcoidosis was 1:0.8 (male:female). The sex ratio of NMOSD was 1:4.6 (male:female). The mean age at the time of MRI for neurosarcoidosis patients was 67.7 years (range 59-78), and that of NMOSD was 55.4 years (range 29-79).
T2*WI of the head showed asymptomatic hemorrhagic lesions in seven out of nine patients with neurosarcoidosis. Of these, five patients had subcortical (Fig. 1a-c) or brainstem microhemorrhages, one patient had a thalamic hemorrhage and one patient had a superficial siderosis (Fig. 1d) . Conversely, two out of 28 NMOSD patients had an asymptomatic subcortical microhemorrhage on T2*WI. Of these, one NMOSD patient had a subcortical microhemorrhage on T2*WI 25 years after disease onset, although no lesion was observed in T2*WI 17 years after onset. The frequency of neurosarcoidosis with hemorrhagic lesions on T2*WI was significantly greater than that of NMOSD with hemorrhagic lesions (P < 0.01; Fisher's exact test). Neither neurosarcoidosis patients nor NMOSD patients presented contrast enhancement consistent with T2*WI lesions. Regarding the number of patients with hypertension, spinal cord compression and systemic steroid administration at the time of the head MRI, there was no significant difference between neurosarcoidosis and NMOSD.
Discussion
We examined the utility of T2*WI of the head for distinguishing neurosarcoidosis from NMOSD. We found that intracranial hemorrhagic lesions of neurosarcoidosis patients was observed more frequently than that of NMOSD patients through this comparative examination of T2*WI. The present study suggests that T2*WI of the head could be useful for distinguishing neurosarcoidosis from NMOSD, and even in myelitis cases, might reveal hemorrhagic brain lesions.
In sarcoidosis, granulomatous inflammation in a perivascular distribution can produce either restricted or generalized vascular involvement. Phlebitis and microhemorrhages have been associated in one neuropathological report, and it is possible that phlebitis due to neurosarcoidosis might result in asymptomatic microhemorrhagic lesions.
2 Alternatively, hypotheses exist suggesting that spinal sarcoidosis lesions spread from the leptomeninges to the spinal cord, or that vasculitis can induce microhemorrhage and subsequently BBB leakage in sarcoidosis. 4 On the contrary, pathological conditions such as vasculitis and hemorrhage-induced BBB leakage are not implicated in NMOSD with AQP4-IgG4.
Conclusion
We showed that the presence of intracranial hemorrhagic lesions on T2*WI help to distinguish neurosarcoidosis from NMOSD. Neurosarcoidosis and NMOSD are often clinically indistinguishable neurological conditions with divergent etiological mechanisms. BBB leakage might be involved in the development of central nervous lesions in sarcoidosis. The present results showed a statistically higher frequency of asymptomatic hemorrhage in neurosarcoidosis patients compared with NMOSD patients, based on T2*WI. Thus, the current study indicates that T2*WI of the head might be useful for distinguishing neurosarcoidosis from NMOSD, even in myelitis cases. 
